Sex | Age | Risk factor | Course | Hb (g/dL) | Platelets (x109/L) | Fg (mg/dL) | Alb (g/dL) | TBIL (mg/dL) | Anticoagulation | Intervention | Outcome | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Male | 68 | Suspected polycythaemia vera, not confirmed | Acute hepatitis | 19.9 | 205 | 294 | 3.0 | 9.7 | LMWH | TIPS | Died |
2 | Male | 54 | Multiple myeloma | Acute hepatitis | 10.2 | 81 | 608 | 3.0 | 2.8 | None | Mechanical thrombectomy | Died |
3 | Male | 39 | Paroxysmal nocturnal haemoglobinuria | Subacute hepatitis | 9.7 | 66 | 427 | NA | 2.1 | LMWH | TIPS | Survived |
4 | Male | 21 | Leukaemia | Acute hepatitis | 15.8 | 196 | 301 | 4.2 | 1.1 | UH | Mechanical thrombectomy | Died |
5 | Female | 78 | Hepatocarcinoma | Cirrhosis | 12.5 | 105 | 325 | 2.9 | 0.8 | None | None | Died |
6 | Female | 84 | Cirrhosis | Cirrhosis | 9.6 | 119 | 335 | 2.4 | 1.4 | LMWHa | None | Died |
7 | Female | 43 | Ovarian cancer | Acute hepatitis | 9.3 | 206 | 511 | 2.7 | 1.1 | LMWH | None | Survived |
8 | Female | 73 | Liver abscess | Subacute hepatitis | 12.1 | 184 | NA | 3.3 | 0.6 | LMWH | None | Survived |
9 | Male | 27 | Not identified | Subacute hepatitis | 13.9 | 169 | 450 | 4.3 | 2.0 | LMWH | None | Survived, developed cirrhosis |
10 | Female | 39 | Factor V Leiden mutation | Subacute hepatitis | 13.5 | 226 | 407 | 4.6 | 0.4 | None | None | Survived |
11 | Female | 79 | Liver abscess | Subacute hepatitis | 10.2 | 464 | 333 | 3.3 | 1.7 | LMWH | None | Died |
12 | Male | 75 | Colorectal cancer | Acute hepatitis | 10.2 | 194 | 676 | 2.3 | 0.9 | LMWH | None | Died |
13 | Female | 29 | Antiphospholipid syndrome and systemic lupus erythematosus | Subacute hepatitis | 8.9 | 81 | 568 | 3.0 | 0.3 | LMWHa | None | Survived |
14 | Male | 51 | Colorectal cancer and liver abscess | Subacute hepatitis | 11.6 | 726 | 715 | 2.7 | 0.6 | LMWH | None | Survived |
15 | Male | 49 | Liver abscess | Subacute hepatitis | 12.4 | 299 | 465 | 3.4 | 0.7 | LMWH | None | Survived |